Stay updated on IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.

Latest updates to the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision: v3.4.2 was added and v3.4.1 was removed, representing a minor administrative update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedRevision: v3.4.1 is now displayed, replacing v3.4.0. This update appears to be a platform-level version change with no impact on the study details or eligibility information.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor metadata/UI change. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a glossary feature; minor wording/capitalization updates to QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria' vs 'Last Update Submitted that met QC Criteria') and capitalization of 'No FEAR Act Data' and 'No FEAR Act data'; and revised the version from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision line updated from v3.3.3 to v3.3.4 on the page footer; no changes to the study details, eligibility criteria, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.3.3 was added and Revision: v3.3.2 was removed, along with the HHS Vulnerability Disclosure link. These are site-versioning and policy-page housekeeping changes that do not modify the study content or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IGUANA Study Assessing MOR106 in Atopic Dermatitis Clinical Trial page.